Carol Feghali-Bostwick to Biomarkers
This is a "connection" page, showing publications Carol Feghali-Bostwick has written about Biomarkers.
Connection Strength
0.451
-
Identification of Impacted Pathways and Transcriptomic Markers as Potential Mediators of Pulmonary Fibrosis in Transgenic Mice Expressing Human IGFBP5. Int J Mol Sci. 2021 Nov 22; 22(22).
Score: 0.129
-
Systemic sclerosis biomarkers detection in the secretome of TGF?1-activated primary human lung fibroblasts. J Proteomics. 2021 06 30; 242:104243.
Score: 0.124
-
Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis. Arthritis Rheum. 2009 Jul 15; 61(7):958-65.
Score: 0.055
-
The pro-fibrotic factor IGFBP-5 induces lung fibroblast and mononuclear cell migration. Am J Respir Cell Mol Biol. 2009 Aug; 41(2):179-88.
Score: 0.053
-
Elevated Fibronectin Levels in Profibrotic CD14+ Monocytes and CD14+ Macrophages in Systemic Sclerosis. Front Immunol. 2021; 12:642891.
Score: 0.032
-
Excessive exosome release is the pathogenic pathway linking a lysosomal deficiency to generalized fibrosis. Sci Adv. 2019 07; 5(7):eaav3270.
Score: 0.027
-
Interferon-gamma inducible protein-10 as a potential biomarker in localized scleroderma. Arthritis Res Ther. 2013; 15(6):R188.
Score: 0.017
-
Autophagic protein LC3B confers resistance against hypoxia-induced pulmonary hypertension. Am J Respir Crit Care Med. 2011 Mar 01; 183(5):649-58.
Score: 0.015